lung cancer

Authors and Affiliations:

José Teixeira^1,2, Ricardo Amorim¹, Katia Santos², Pedro Soares¹, Sandipan Datta³, Gino A. Cortopassi³, Teresa L. Serafim², Vilma A. Sardão², Jorge Garrido^1,4, Fernanda Borges¹, Paulo J. Oliveira²

¹ CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal

Authors and Affiliations:

Estela Maria Silva^1#, Vânia Sammartino Mariano^1#, Paula Roberta Aguiar Pastrez¹, Miguel Cordoba Pinto², António Gil Castro^3,4, Kari Juhani Syrjanen⁵, Adhemar LongattoFilho1,3,4,6

¹ Teaching and Research Institute, Barretos Cancer Hospital–Pio XII Foundation, Barretos, Sao Paulo, Brazil,

² Department of Chest, Barretos Cancer Hospital–Pio XII Foundation, Barretos, Sao Paulo, Brazil,

Autores e Afiliações:

Estela Maria Silva^1#, Vânia Sammartino Mariano^1#, Paula Roberta Aguiar Pastrez¹, Miguel Cordoba Pinto², António Gil Castro^3,4, Kari Juhani Syrjanen⁵, Adhemar LongattoFilho1,3,4,6

¹ Teaching and Research Institute, Barretos Cancer Hospital–Pio XII Foundation, Barretos, Sao Paulo, Brazil,

² Department of Chest, Barretos Cancer Hospital–Pio XII Foundation, Barretos, Sao Paulo, Brazil,

The Midland Hotel, Manchester, United Kingdom

03 - 05 December, 2017

See more informations here: http://www.cancerresearchuk.org/funding-for-researchers/research-events-and-conferences/the-lung-cancer-centre-of-excellence-conference-2017

The Midland Hotel, Manchester, United Kingdom

03 - 05 December, 2017

See more informations here: http://www.cancerresearchuk.org/funding-for-researchers/research-events-and-conferences/the-lung-cancer-centre-of-excellence-conference-2017

Royal Society of Medicine, London, United Kingdom

01 - 02 September, 2016

See more informations here: http://www.futurehorizonsinlungcancer.org/

Royal Society of Medicine, London, United Kingdom

01 - 02 September, 2016

See more informations here: http://www.futurehorizonsinlungcancer.org/

The bacterial protein azurin and its derived peptide (p28) have been shown to possess anticancer activities. Up to date, several in vitro and in vivo studies have reported their multi-targeted anticancer properties. Moreover, p28, a cell-penetrating peptide, has completed two US phase I trials with promising results.

Ionizing radiation presents itself in the form of particles (alpha particles, beta particles, protons or neutrons) or electromagnetic radiation (gamma rays and X-rays) with characteristic ionizing power and penetration. Radiotherapy is an essential tool in the treatment of cancer. We can consider various forms of radiation such as external beam radiotherapy, brachytherapy and metabolic radiotherapy. When treating cancer with ionizing radiation all cells within the irradiation volume are more or less exposed.

Non-small-cell lung cancer (NSCLC) is one of the most common causes of cancer-related death worldwide. In this type of cancer, immunotherapy has shown inconsistent efficacy, due to our limited understanding of the molecular and cellular interactions developed during carcinogenesis.